Phathom Pharmaceuticals, Inc.·4

May 31, 6:37 PM ET

Henderson Molly 4

4 · Phathom Pharmaceuticals, Inc. · Filed May 31, 2024

Insider Transaction Report

Form 4
Period: 2024-05-31
Henderson Molly
CFO and CBO
Transactions
  • Award

    Common Stoock

    2024-05-31+7,500102,763 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,911.27
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4